Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target / Fenotipska heterogenost u staničnoj liniji NCI-H125 utječe na biološku aktivnost na receptore za epidermalni faktor rasta

1. R. S. Herbst, Review of epidermal growth factor receptor biology, Int. J. Radiat. Oncol. Biol. Phys. 59 (2004) 21-26; DOI: 10.1016/j.ijrobp.2003.11.041.10.1016/j.ijrobp.2003.11.04115142631Search in Google Scholar

2. H. Zhang, A. Berezov, Q. Wang, G. Zhang, J. Drebin, R. Murali and M. I. Greene, ErbB receptors: from oncogenes to targeted cancer therapies, J. Clin. Invest. 117 (2007) 2051-2058; DOI: 10.1172/JCI32278.10.1172/JCI32278193457917671639Search in Google Scholar

3. A. Kendall, R. Lord and N. Maisey, Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer, Recent. Pat. Anticancer Drug Discov. 5 (2010) 142-151; DOI: 10. 2174/157489210790936270.10.2174/15748921079093627019954416Search in Google Scholar

4. M. S. Ramakrishnan, A. Eswaraiah, T. Crombet, P. Piedra, G. Saurez, H. Iyer and A. S. Arvind, Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin, mAbs 1 (2009) 41-48; DOI: 10.4161/mabs.1.1.7509.10.4161/mabs.1.1.7509271518120046573Search in Google Scholar

5. R. C. Chatelier, R. G. Ashcroft, C. J. Lloyd, E. C. Nice, R. H. Whitehead, W. H. Sawyer and A.W. Burgess, Binding of fluoresceinated epidermal growth factor to A431 cell sub-populations studied using a model-independent analysis of flow cytometric fluorescence data, EMBO 5 (1986) 1181-1186.10.1002/j.1460-2075.1986.tb04344.x11669253015587Search in Google Scholar

6. N. B. S. Abid, Z. Rouis, F. Nefzi, N. Souelah and M. Aouni, Evaluation of dimethylthiazol diphenyl tetrazolium bromide and propidium iodide inclusion assays for the evaluation of cell viability by flow cytometry, J. Appl. Pharm. Sci. 2 (2012) 10-14; DOI: 10.7324/JAPS.2012.2525.10.7324/JAPS.2012.2525Search in Google Scholar

7. A. L. Givan, Critical Aspects of Staining for Flow Cytometry, in Living Color: Protocols in Flow Cytometry and Cell Sorting (Eds. R. Diamond and S. DeMaggio), 1st ed., Springer, Berlin 2000, pp. 142-164.Search in Google Scholar

8. W. K. Boland and G. Bebb, Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity, Expert Opin. Biol. Ther. 9 (2009) 1-8; DOI: 10.1517/14712590903110709.10.1517/1471259090311070919624281Search in Google Scholar

9. J. M. Reichert, Antibody-based therapeutics to watch in 2011, mAbs 3 (2011) 76-99; DOI: 10.4161/mabs.3.1.13895.10.4161/mabs.3.1.13895303801421051951Search in Google Scholar

10. R. I. Freshney, Basic Principles of Cell Culture, in Culture of Cells for Tissue Engineering (Eds. G. Vunjak-Novakovic and R. I. Freshney), John Wiley, New York 2006, pp. 11-14.10.1002/0471741817.ch1Search in Google Scholar

11. G. Rothe, Technical Background and Methodological Principles of Flow Cytometry, in Cellular Diagnostics. Basics, Methods and Clinical Applications of Flow Cytometry (Eds. U. Sack, A. Tarnok and G. Rothe), Karger, Basel 2009, pp. 53-88; DOI: 10.1159/000209156.10.1159/000209156Search in Google Scholar

12. G. N. Gill and C. S. Lazar, Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells, Nature 293 (1981) 305-307.10.1038/293305a06268987Search in Google Scholar

13. L. Nikfarjam and P. Farzaneh, Prevention and detection of mycoplasma contamination in cell culture, Cell J. (Yakhteh) 13 (2012) 203-212.Search in Google Scholar

14. T. Mammone, D. Gan and R. Foyouzi-Youssefi, Apoptotic cell death increases with senescence in normal human dermal fibroblast cultures, Cell Biol. Int. 30 (2006) 903-909; DOI: 10.1016/j.cellbi.2006.06.010.10.1016/j.cellbi.2006.06.01016904918Search in Google Scholar

15. S. Gupta, S. R. Indelicato, V. Jethwa, T. Kawabata, M. Kelley, A. R. Mire-Sluis, S. M. Richards, B. Rup, E. Shores, S. J. Swanson and E. Wakshull, Recommendations for the design optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics, J. Immunol. Met. 321 (2007) 1-18; DOI: 10.1016/j.jim.2004.06.002.10.1016/j.jim.2004.06.00215251407Search in Google Scholar